Results 181 to 190 of about 67,755 (267)

Hairy Cell Leukemia With Aberrant CD5 and CD23 Expression: A Case Report and a Brief Literature Review. [PDF]

Cureus
Alameddine Z, Hamadi R, Attia H, Zhonghua L, Levy R.   +4 more
europepmc   +1 more source

Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Immunosuppressive disease was associated with reduced overall survival, while anticoagulant use was linked to prolonged progression‐free survival in advanced cutaneous squamous cell carcinoma treated with immune checkpoint inhibitors. Host‐related factors may modulate immunotherapy efficacy and warrant prospective validation.
Glenn Geidel, Sabrina Bänsch, Laura Adam, Nathan Fekade, Alessandra Rünger, Tim Zell, Daniel J. Smit, Julian Kött, Isabel Heidrich, Michael Weichenthal, Selma Ugurel, Ulrike Leiter, Peter Mohr, Alexandra Geusau, Stephan Grabbe, Markus V. Heppt, Ralf Gutzmer, Jochen Utikal, Jan‐Christoph Simon, Sebastian Haferkamp, Laura Susok, Bastian Schilling, Edgar Dippel, Imke von Wasielewski, Jessica C. Hassel, Carola Berking, Stefan W. Schneider, Christoffer Gebhardt   +27 more
wiley   +1 more source

Oral manifestations and dental management in patients undergoing CAR-T cell therapy: a retrospective observational study. [PDF]

Support Care Cancer
de Paula Eduardo F, Menti LD, Ferreira MH, de Carvalho DLC, de Paula Novaes C, da Silva Martins BH, Kerbauy LN, Hamerschlak N, Bezinelli LM.   +8 more
europepmc   +1 more source

Simulated daylight versus conventional PDT for mild to moderate actinic keratoses: A randomized controlled trial

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This single‐centre, randomized controlled trial showed that simulated daylight photodynamic therapy (SDL‐PDT, n = 785 lesions) was less effective than conventional photodynamic therapy (C‐PDT, n = 673 lesions) in treating mild to moderate actinic keratoses with 1‐year clearance rates of 71.0% for SDL‐PDT versus 85.3% for C‐PDT (p < 0.001). However, SDL‐
Alexandra Sjöholm, Eva Backman, Maja Modin, Julia Fougelberg, Magdalena Claeson, John Paoli   +5 more
wiley   +1 more source

Acute Acalculous Cholecystitis Mimicry: Symptomatic Hepatic Infiltration From Chronic Lymphocytic Leukemia Presenting as Cholestatic Liver Injury. [PDF]

ACG Case Rep J
Alnounou A, Zou H, Boamah H.
europepmc   +1 more source

Genomic Medicine Sweden: Advancing precision medicine at the national level

Journal of Internal Medicine, EarlyView.
Abstract High‐throughput sequencing has transformed clinical diagnostics of rare diseases (RD), cancer and infectious diseases by enabling the identification of disease‐causing genetic alterations and facilitating individualised treatment and care.
Anders Edsjö, Anna Lindstrand, Panagiotis Baliakas, David Gisselsson, Paula Mölling, Mia Wadelius, Åsa Johansson, Hannes Olauson, Hans Ehrencrona, Lovisa Lovmar, Christian G. Giske, Henrik Green, Ann Nordgren, Fulya Taylan, Martin Hallbeck, Erika Tång Hallbäck, Anna Green, Markus Heidenblad, Kina Höglund, Anders Jemt, Carl Mårten Lindqvist, Maria Johansson Soller, Magnus Sabel, Colum Walsh, Hartmut Vogt, Craig E. Wheelock, Martin Bergö, Jens Enoksson, Ann Ekberg Jansson, Cecilia Fagerström, Jan Holgersson, Stephanie Anja Juran, Mats G. Karlsson, Frida Lundmark, Eva Tiensuu Janson, Andreas Muranyi Scheutz, Malin Sund, Päivi Östling, Sofia Gruvberger‐Saal, Marene Landström, Malin Melin, Lars Palmqvist, Richard Palmqvist, Bianca Stenmark, Anna Wedell, Malin Karnå, Katarina Nyström, Tobias Strid, Per Sikora, Maria Johansson, Therese Fagerqvist, Mirja Carlsson Möller, Oskar Frisell, Mats Ulfendahl, Mikaela Friedman, Lucia Cavelier, Valtteri Wirta, Thoas Fioretos, Richard Rosenquist   +58 more
wiley   +1 more source

Lymphocyte count and risk of chronic lymphocytic leukemia. [PDF]

J Natl Cancer Inst
Pahnke S, Alcala K, Bulos Salim C, Cortez Cardoso Penha R, Park HA, Mckay J, Johansson M.   +6 more
europepmc   +1 more source

Advances in the treatment of systemic lupus erythematosus: Biologicals, small‐molecular agents, and cell‐depleting therapies coming to the clinic

Journal of Internal Medicine, EarlyView.
Abstract Systemic lupus erythematosus (SLE; lupus) remains a particular challenge for the practicing clinician on account of its chronic undulating and unpredictable course, its diverse manifestations, and—until recently—limited treatment options all associated with considerable downsides.
Ronald van Vollenhoven
wiley   +1 more source

Auer Rod-Like Inclusions in Chronic Lymphocytic Leukemia: A Case Report. [PDF]

Clin Case Rep
Zhang T, Xie L.
europepmc   +1 more source

Leukemia cutis (chronic lymphocytic leukemia-low grade B cell)

Dermatology Online Journal, 2002
openaire   +4 more sources